Enhancing Engagement of Partners in Research
Enhancing Stakeholder Engagement in Pediatric Research
2 other identifiers
interventional
480
1 country
1
Brief Summary
The purpose of this study is to examine the implementation and effectiveness of a bundle of engagement strategies for pediatric patient centered outcomes research (PCOR) studies. The study aims to examine the effectiveness of a "bundle" of enhanced engagement strategies on improved stakeholder engagement and study protocol indicators (including improved language access, meeting recruitment/retention goals) compared to standard practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 8, 2025
CompletedFirst Submitted
Initial submission to the registry
September 9, 2025
CompletedFirst Posted
Study publicly available on registry
September 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
September 16, 2025
September 1, 2025
1.2 years
September 9, 2025
September 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Research Engagement Survey Tool (REST) stakeholder engagement score
This tool consists of 32 items and assesses engagement across 8 domains, using a 5-point Likert scale for each item. The 8 domains include: 1) focus on community perspectives and determinants of health, 2) partner input, 3) partnership sustainability, 4) fostering co-learning, capacity building and co-benefit, 5) building on strengths and resources, 6) facilitating collaborative, equitable partnerships, 7) involving partners in the dissemination process, and 8) building and maintaining trust. Engagement principle (EP) scores are calculated as an average of non-missing items. The 8 means are used to calculate the overall stakeholder engagement score. Higher scores indicate higher degree of stakeholder engagement.
Month 6
Secondary Outcomes (3)
Patient Engagement in Research Scale (PEIRS) stakeholder engagement score
Month 6
Reading grade level of written materials
Month 6
Patient Education Materials Assessment Tool (PEMAT) score
Month 6
Study Arms (2)
Enhanced Strategies
EXPERIMENTALSubjects assigned to the Enhanced Strategies arm will receive a toolkit of enhanced stakeholder engagement strategies.
Standard Practice
NO INTERVENTIONNo Intervention. Participants will continue to implement standard practices used by investigator
Interventions
The toolkit contains information regarding enhanced stakeholder engagement strategies. The toolkit includes guidance materials, checklists, and templates/ sample materials, to increase stakeholder engagement in the research. This includes guidance on setting up a stakeholder advisory board (SAB) and ensuring literacy- and language- sensitivity of participant-/stakeholder-facing materials.
Eligibility Criteria
You may qualify if:
- In order to be eligible to participate in this study, PIs must oversee a study that meets the following criteria:
- Studies who either have not started enrollment or are within 1-3 months of the start of enrollment, and within the 25% ceiling for % recruitment target.
- Studies that have started enrollment must be no further than 25% of projected enrollment timeline of the study (with at least 6 months remaining for enrollment).
- Target n\>50 participants in study.
- At least 10 stakeholder partners part of study. The PI's must also be ≥18 years old;
- In order for study stakeholders to be eligible to participate in this study, an individual must meet all of the following criteria:
- \>=12 years old;
- Ability to speak either English, Spanish, or Chinese, and;
- Part of the study team or serving in an advisory capacity to the study team
- The same criteria as that used for stakeholder and PI eligibility applies to Key informant (KI) interviews.
You may not qualify if:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Not able to complete 6 month follow-up assessment
- Children who are wards/foster children
- Not able or willing to provide consent.
- Concurrent enrollment in another study that is part of this research project.
- In addition, PI's who meet the following criteria will be excluded from participation in this study:
- \. A lot of experience with stakeholder engagement (based on screener survey question)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NYU Langone Healthlead
- Patient-Centered Outcomes Research Institutecollaborator
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
Study Officials
- PRINCIPAL INVESTIGATOR
H. Shonna Yin, MD, MS
NYU Langone Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2025
First Posted
September 11, 2025
Study Start
September 8, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
September 16, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to Hsiang.Yin@nyulangone.org. To gain access, data requestors will need to sign a data access agreement. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's DSSB.
The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to: Hsiang.Yin@nyulangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.